Literature DB >> 17252179

Conservative management of renal masses in the elderly: our experience.

Herman S Fernando1, Sudhir Duvuru, Simon J Hawkyard.   

Abstract

OBJECTIVES: To analyse a group of patients with clinically and radiologically detected renal neoplasms who were conservatively treated for various reasons. The patients were followed-up radiologically and intervened only if symptomatic. The natural progression of these masses and also a brief review of the literature is done.
METHODS: The series was collected retrospectively from the case-notes of patients coded for renal neoplasms. Of the 13 patients followed up conservatively, eight were deferred surgery in view of their age (mean age-83.25 years), one patient had a single kidney, two were unwilling for surgery and two had severe co-morbidities which made them unfit for surgery.
RESULTS: The mean age at diagnosis was 80.4 years (median-82; range 66-88). Seven females and six males were followed up for a mean and median follow-up of 38.38 and 34 months respectively (range-19 to 105 months). Six patients died during follow-up (mean-41.57 months). The average longest dimension at diagnosis and when last reviewed were 5.01 cm and 5.57 cm. However, only one of these died due to metastasis which developed during follow-up and two had to be angio-embolised for hematuria. The average rate of growth along the longitudinal dimension was 0.17 cm/year while the average change in volume was 11.97 cc/year.
CONCLUSIONS: Malignant renal neoplasms grow at a relatively slow rate. Without tumour growth the risk of metastasis appears limited. Thus expectant management can be considered as an alternative for a selected group of patients who are either unwilling or unfit or high risk for surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17252179     DOI: 10.1007/s11255-006-9119-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  18 in total

1.  Clinically unrecognized renal cell carcinoma. Diagnostic and pathological aspects.

Authors:  S Hellsten; J Johnsen; T Berge; F Linell
Journal:  Eur Urol       Date:  1990       Impact factor: 20.096

2.  Surgical management of renal tumors 4 cm. or less in a contemporary cohort.

Authors:  C T Lee; J Katz; W Shi; H T Thaler; V E Reuter; P Russo
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

3.  Growth rates of primary and metastatic lesions of renal cell carcinoma.

Authors:  T Oda; N Miyao; A Takahashi; M Yanase; N Masumori; N Itoh; M Tamakawa; T Tsukamoto
Journal:  Int J Urol       Date:  2001-09       Impact factor: 3.369

4.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

Review 5.  Observation of small incidentally detected renal masses.

Authors:  M A Bosniak
Journal:  Semin Urol Oncol       Date:  1995-11

6.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

Review 7.  Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy.

Authors:  Michael J Wehle; David D Thiel; Steven P Petrou; Paul R Young; Igor Frank; Nolan Karsteadt
Journal:  Urology       Date:  2004-07       Impact factor: 2.649

8.  Natural history of renal masses followed expectantly.

Authors:  W Kassouf; A G Aprikian; M Laplante; S Tanguay
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

9.  Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935-1989.

Authors:  D L Katz; T Zheng; T R Holford; J Flannery
Journal:  Int J Cancer       Date:  1994-07-01       Impact factor: 7.396

10.  Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma.

Authors:  D F R Griffiths; A Verghese; A Golash; H G Kynaston; P N Matthews; A J L Hart; J B Court
Journal:  BJU Int       Date:  2002-07       Impact factor: 5.588

View more
  6 in total

Review 1.  Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.

Authors:  Marc C Smaldone; Alexander Kutikov; Brian L Egleston; Daniel J Canter; Rosalia Viterbo; David Y T Chen; Michael A Jewett; Richard E Greenberg; Robert G Uzzo
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

2.  Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention.

Authors:  Xue-Song Li; Lin Yao; Kan Gong; Wei Yu; Qun He; Li-Qun Zhou; Zhi-Song He
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-22       Impact factor: 4.553

Review 3.  Active surveillance of small renal masses.

Authors:  Marc C Smaldone; Anthony T Corcoran; Robert G Uzzo
Journal:  Nat Rev Urol       Date:  2013-04-09       Impact factor: 14.432

4.  Available active surveillance follow-up protocols for small renal mass: a systematic review.

Authors:  Giacomo Rebez; Nicola Pavan; M Carmen Mir
Journal:  World J Urol       Date:  2021-01-16       Impact factor: 4.226

5.  Growth Pattern of Clear Cell Renal Cell Carcinoma in Patients with Delayed Surgical Intervention: Fast Growth Rate Correlates with High Grade and May Result in Poor Prognosis.

Authors:  Lei Zhang; Wenshi Yin; Lin Yao; Xuesong Li; Dong Fang; Da Ren; Zhongyuan Zhang; Yu Fan; Qun He; Weimin Ci; Zhisong He; Liqun Zhou
Journal:  Biomed Res Int       Date:  2015-09-03       Impact factor: 3.411

Review 6.  Natural history of small renal masses.

Authors:  Lei Zhang; Xue-Song Li; Li-Qun Zhou
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.